View Older Stories View More Recent Stories

Jun 2, 2022 08:00AM New Social Media Campaign From Bausch + Lomb Aims to Raise Awareness that Cataracts Don't Wait
Jun 2, 2022 07:02AM Bausch + Lomb Corporation (BLCO) Announce US Launch of Biotrue Hydration Plus Multi-Purpose Solution
Jun 2, 2022 07:00AM Bausch + Lomb Announces the U.S. Launch of Biotrue® Hydration Plus Multi-Purpose Solution
May 25, 2022 07:00AM Bausch + Lomb Will Release First-Quarter 2022 Financial Results on June 8
May 24, 2022 06:59AM Bausch + Lomb Corporation (BLCO) Granted Canadian Approval of LUMIFY Redness Reliever Eye Drops
May 24, 2022 06:59AM Bausch + Lomb Receives Health Canada Approval of LUMIFY® Redness Reliever Eye Drops
May 17, 2022 05:49AM Bausch + Lomb Corporation (BLCO) Reports Q1 Revenue of $889M, Net Income of $20M
May 16, 2022 07:17PM Bausch + Lomb Corporation Files Financial Statements for the First Quarter of 2022
May 13, 2022 07:00AM Bausch + Lomb Announces Participation at the RBC Capital Markets Global Healthcare Conference
May 12, 2022 06:59AM New Survey Shows Retina Specialists Believe Suprachoroidal Administration is an Option for Patients With Macular Edema Associated With Noninfectious Uveitis
May 6, 2022 12:15PM Bausch + Lomb Corporation (BLCO) Commences Trading as Separate Public Company
May 6, 2022 12:10PM BAUSCH + LOMB CORPORATION LAUNCHES AS A PUBLICLY TRADED COMPANY
View More Recent Stories View Older Stories